Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 342

1.

Induction cisplatin and paclitaxel followed by combination chemoradiotherapy with 5-fluorouracil, cisplatin, and paclitaxel before resection in localized esophageal cancer: a phase II report.

Henry LR, Goldberg M, Scott W, Konski A, Meropol NJ, Freedman G, Weiner LM, Watts P, Beard M, McLaughlin S, Cheng JD.

Ann Surg Oncol. 2006 Feb;13(2):214-20. Epub 2006 Jan 18.

PMID:
16418887
2.

Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.

Kim DW, Blanke CD, Wu H, Shyr Y, Berlin J, Beauchamp RD, Chakravarthy B.

Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):397-404. Epub 2006 Nov 9.

PMID:
17097833
3.

Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.

Choi N, Park SD, Lynch T, Wright C, Ancukiewicz M, Wain J, Donahue D, Mathisen D.

Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):111-22.

PMID:
15337546
4.

Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.

Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J Jr, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):427-36.

PMID:
15380576
5.
6.

Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial.

Meluch AA, Greco FA, Gray JR, Thomas M, Sutton VM, Davis JL, Kalman LA, Shaffer DW, Yost K, Rinaldi DA, Hainsworth JD.

Cancer J. 2003 Jul-Aug;9(4):251-60.

PMID:
12967135
7.

Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer.

Kleinberg L, Knisely JP, Heitmiller R, Zahurak M, Salem R, Burtness B, Heath EI, Forastiere AA.

Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):328-34.

PMID:
12738305
8.

[Concurrent standard dose of cisplatin, paclitaxel, and radiotherapy followed by surgery in treatment of thoracic esophageal carcinoma].

Jiang YY, Wu SX, Zhang P, Xie CY, Wang J, Sun CC.

Zhonghua Yi Xue Za Zhi. 2008 Aug 12;88(31):2171-4. Chinese.

PMID:
19080664
9.

Long-term survival following induction chemoradiotherapy and esophagectomy for esophageal carcinoma.

Lew JI, Gooding WE, Ribeiro U Jr, Safatle-Ribeiro AV, Posner MC.

Arch Surg. 2001 Jul;136(7):737-42; discussion 743.

PMID:
11448381
10.

Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.

Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP.

Ann Thorac Surg. 2008 Jun;85(6):1930-6; discussion 1936-7. doi: 10.1016/j.athoracsur.2008.01.097.

PMID:
18498797
12.

A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction.

Ajani JA, Komaki R, Putnam JB, Walsh G, Nesbitt J, Pisters PW, Lynch PM, Vaporciyan A, Smythe R, Lahoti S, Raijman I, Swisher S, Martin FD, Roth JA.

Cancer. 2001 Jul 15;92(2):279-86.

PMID:
11466680
13.

Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensification.

Seung SK, Smith JW, Molendyk J, Bader SB, Phillips M, Regan J, Louie J, Soo E, Seligman M, Ruzich J, Skokan L, Ross HJ.

Semin Oncol. 2004 Dec;31(6 Suppl 18):13-9.

PMID:
15726517
14.

Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.

Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD, Haffty BG, Son YH, Ross DA, Weinberger PM, Chung GG, Zelterman D, Burtness BA, Cooper DL.

J Clin Oncol. 2004 Aug 1;22(15):3061-9.

PMID:
15284256
15.

Survival following intensive preoperative combined modality therapy with paclitaxel, cisplatin, 5-fluorouracil, and radiation in resectable esophageal carcinoma: a phase I report.

Goldberg M, Farma J, Lampert C, Colarusso P, Coia L, Frucht H, Goosenberg E, Beard M, Weiner LM.

J Thorac Cardiovasc Surg. 2003 Oct;126(4):1168-73.

16.

Preoperative chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction.

Posner MC, Gooding WE, Landreneau RJ, Rosenstein MM, Clarke MR, Peterson MS, Lembersky BC.

Cancer J Sci Am. 1998 Jul-Aug;4(4):237-46.

PMID:
9689982
17.

Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer.

Lin CC, Hsu CH, Cheng JC, Huang CY, Tsai YC, Hsu FM, Huang KH, Cheng AL, Pu YS.

Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):442-8. doi: 10.1016/j.ijrobp.2008.11.030. Epub 2009 Mar 21.

PMID:
19307067
18.

Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer.

Swisher SG, Ajani JA, Komaki R, Nesbitt JC, Correa AM, Cox JD, Lahoti S, Martin F, Putnam JB, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA.

Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):120-7.

PMID:
12909224
19.

Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma.

Adelstein DJ, Rice TW, Becker M, Larto MA, Kirby TJ, Koka A, Tefft M, Zuccaro G.

Cancer. 1997 Sep 15;80(6):1011-20.

PMID:
9305700
20.

[Chemoradiotherapy followed by surgery in treatment of locally advanced esophageal carcinoma: a phase II trial].

Fu JH, Rong TH, Li XD, Hu Y, Ou W, Hu YH, Li Q.

Ai Zheng. 2004 Nov;23(11 Suppl):1473-6. Chinese.

PMID:
15566661

Supplemental Content

Support Center